Deal of the Day — limited-time pharmacy picks!
Cistero 50mg Injection

Cistero 50mg Injection

Prescription requiredRx Required

Salt Composition: Cisplatin

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 injection

About The Product

Ovarian Cancer

Cistero 50mg injection is a chemotherapy medication that is used to treat multiple carcinomas and sarcomas. It is primarily used in the treatment of ovarian cancer. It is also used to treat bladder, cervical, and testicular cancer.

The generic name of this medication is Cisplatin. Cisplat is a prescription-based medication that should be injected by a doctor or an experienced nurse only. This drug functions as an alkylating agent.

Uses

  • Testicular tumour
  • Ovarian tumour
  • Bladder tumour
  • Lung cancer
  • Head and neck epithelial tumour
  • Cervical cancer

Side Effects

Cistero 50mg injection may cause various side effects during treatment. There are chances when these reactions become serious; in such cases, contact your doctor immediately.

  • Fever
  • Infection​
  • Vomiting
  • Chills
  • Hearing loss Skin rash
  • Back pain
  • Stomach pain
  • Swelling on the face
  • Shortness of breath
  • Sudden shivering

How To Use

  • Take the dose as per your healthcare provider’s prescription.
  • Do not stop taking the medicine suddenly, unless your doctor tells you.
  • This injection is given under the strict supervision of a doctor.
  • Do not self-administer.
  • This injection is given into the veins by a qualified healthcare provider.
  • Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider.

How It Works

An anti-cancer medication, Cistero50mg injection, works by stopping the growth and multiplication of cancer cells by damaging the genetic material (RNA and DNA) of the cancer cells.

It does this by binding to the DNA in the cancer cells and preventing them from replicating.

Safety Advice

Alcohol

It is advisable not to consume alcohol while taking medicine. The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Cistero 50mg injection. Consult your doctor for further information.

Pregnancy

Do not consume Cistero 10mg injection without consulting the doctor, in case of pregnancy. Cistero 50mg injection may be considered unsafe during pregnancy. Please consult your doctor in such a condition. According to some research data, taking Cistero 50mg injection during pregnancy has shown harmful effects on the developing baby.

Breast Feeding

Without a doctor's consultation, do not take this medicine if you're breastfeeding. Cistero 50mg injection is probably not safe if you're breastfeeding. Kindly consult your doctor before taking Cistero 50mg injection while breastfeeding, as there are chances that it may pass to the developing baby through the breast milk of the mother.

Driving

It is advisable not to drive or operate heavy machinery, as one of the side effects of the medicine. It is advisable not to drive or operate heavy machinery after taking Cistero 50mg injection, as you may feel dizzy.

Kidney

Do not take Cistero 10mg injection without a doctor's consultation in case of kidney problems. Share your medical history with your healthcare expert in case of kidney disease before taking Cistero 50mg injection. Patients with renal impairment must be careful while taking Cistero 50mg injection. They may require adjustment in the dose.

Liver

Share your medical history with the doctor in case of liver disease. Inform your doctor before starting Cistero 50mg injection. If you have liver disease, avoid any serious side effects. Patients with hepatic impairment must be careful while taking Cistero 50mg injection. They may require adjustment in the dose.

Missed Doses

  • If you miss a dose, consult your healthcare provider.
  • Your provider will suggest a possible way to compensate.

FAQs

Cistero 50mg Injection is a medication that is used in the treatment of Metastatic testicular tumors, Metastatic ovarian tumors, Advanced bladder cancer, and other related conditions.

Reference

  • Heinhuis KM, Ros W, Kok M, et al. (2023). Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors. Ann Oncol. 30(2): 219–235 - https://pubmed.ncbi.nlm.nih.gov/30608567/
  • Yeku O, Russo AL, Lee H, et al. (2024). A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma. J Transl Med.18(1): 350 - https://pubmed.ncbi.nlm.nih.gov/32928237/
  • Wu NL, Hingorani S (2025). Outcomes of kidney injury, including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients. Pediatr Nephrol 36:2675–2686 - https://pubmed.ncbi.nlm.nih.gov/33411070/
  • World Health Organization. (2023). World Health Organization model list of essential medicines for children: 8th list. World Health Organization.
  • Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V et al (2024). Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife-edge between renoprotection and tumor toxicity. J Biomed Sci 26:25.
  • Kooijmans E, Van der Pal HJ, Pluijm S, Bresters D, Van Dulmen-den Broeder E, Van der Heiden-van der Loo, Margriet, Van den Heuvel-eibrink MM, Kremer L, Loonen J, Louwerens M, Ronckers CM. (2024). TUBULAR DYSFUNCTION AND TREATMENT-RELATED RISK FACTORS IN LONG-TERM CHILDHOOD CANCER SURVIVORS; DCCSS-LATER 2: RENA. In PEDIATRIC NEPHROLOGY 2021 Oct 1 (Vol. 36, No. 10, pp. 3307-3307). ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES: SPRINGER.
  • Iwhiwhu, S.A., Kumar, R., Khan, A.H. et al. (2024). A low-dose pemetrexed-cisplatin combination regimen induces significant nephrotoxicity in mice. BMC Nephrol 25, 370.
  • Hayati F, Hossainzadeh M, Shayanpour S, Abedi-Gheshlaghi Z, Beladi Mousavi SS. (2025). Prevention of cisplatin nephrotoxicity. J Nephropharmacol 5(1):57-60 - https://pubmed.ncbi.nlm.nih.gov/28197500/
  • Siddik ZH. (2025). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22(47):7265-79.
  • Arif Akyildiz et al. (2023). The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG). JCO 42, e17534-e17534 - https://pubmed.ncbi.nlm.nih.gov/38950923/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026